Amanote Research

Amanote Research

    RegisterSign In

Appearance of ANCA – Associated Vasculitis Under Tumor Necrosis Factor-Alpha Inhibitors Treatment

American Journal of Case Reports - United States
doi 10.12659/ajcr.883841
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

January 1, 2013

Authors
Tatiana ReitblatOlga Reitblat
Publisher

International Scientific Information, Inc.


Related search

Anca-Associated Vasculitis

The Journal of scientific articles Health and Education millennium
2018English

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

Genetics of ANCA-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
2019English

Animal Models of ANCA Associated Vasculitis

Frontiers in Immunology
AllergyImmunology
2020English

Rheumatoid Arthritis With ANCA Associated Vasculitis

Internet Journal of Rheumatology and Clinical Immunology
2018English

Proteinase 3-Anca Vasculitis Versus Myeloperoxidase-Anca Vasculitis

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Chronic Recurrent Multifocal Osteomyelitis: Treatment With a Tumor Necrosis Factor-Alpha Inhibitor

Turkish Journal of Rheumatology
2013English

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Archives of Dermatology
2010English

Tumor Necrosis Factor Alpha Mediates Neuromuscular Synapse Elimination

Cell Discovery
BiochemistryGeneticsCell BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy